Protocol 2: Difference between revisions

From yangwa
Line 1: Line 1:
<div style="color: black !important; font-family: 'Times New Roman', SimSun, serif !important, line-height:1.5;">
<div style="color: black !important; font-family: 'Times New Roman', SimSun, serif !important, line-height:1.5;">
== Protocol ==
== Antibody conjuagted DNA ==
=== Triplex DNA pH  Test===
=== Reagents and stock solutions ===
* ''Antibody (lexatumumab)'': 50 &mu;M stock; prepare 10 &mu;M working solution by dilution in 1× PBS.
* ''TCEP'': 10 mM stock; prepare 100 &mu;M working solution by dilution in nuclease-free water.
* ''Mal-PEG4-DBCO'': 10 mM stock (DMSO); 1 mM working solution (DMSO).
* ''SsDNA-Azide'': 1 mM stock (nuclease-free water).
* ''Citrate buffer'': 100 mM, pH 5.5.
 
=== 1. Preparation of Mal–DNA ===
* Combine Mal‑PEG4‑DBCO and SsDNA at a 1:2 molar ratio. Example preparation (nominal final concentration 100 &mu;M for Mal‑PEG4‑DBCO):
{| class="wikitable"
! Component
! Volume
|-
| Mal-PEG4-DBCO (stock)
| 2 &mu;L
|-
| SsDNA (stock)
| 4 &mu;L
|-
| 1× PBS (pH 6.5)
| 14 &mu;L
|}
* Incubate the mixture at room temperature for 4 h.
 
=== 2. Antibody reduction ===
* Pre-dilute TCEP into citrate buffer (pH 5.5) before mixing with antibody to avoid antibody inactivation (TCEP stock is acidic).
* Example reduction mixture:
{| class="wikitable"
! Component
! Volume
|-
| Antibody (stock)
| 10 &mu;L
|-
| TCEP (stock, pre-diluted)
| 5 &mu;L
|-
| Citrate buffer (100 mM, pH 5.5)
| 85 &mu;L
|}
* Incubate at 37 &deg;C for 2 h to reduce disulfides and generate free thiols.
* Remove excess TCEP and exchange buffer to 1× PBS (pH 6.5) by ultrafiltration (centrifugal concentrator), performing four washes. Target final antibody volume: ~10–30 &mu;L.
 
=== 3. Antibody–DNA conjugation ===
* Because Mal‑DNA contains DMSO (~10%), dilute the Mal‑DNA in PBS prior to addition to antibody.
* Example conjugation setup:
{| class="wikitable"
! Component
! Volume / notes
|-
| Reduced antibody (from step 2)
| ''variable'' (see note)
|-
| Mal-DNA (prepared in step 1)
| 5 &mu;L
|-
| 1× PBS (pH 6.5)
| ~50 &mu;L (to reach desired antibody:Mal‑DNA ratio; example uses ~1:5)
|}
* Incubate under appropriate conditions (e.g., room temperature for 1–4 h or 4 &deg;C overnight) to allow maleimide–thiol coupling.
* Purify the conjugate by ultrafiltration/washing with 1× PBS (pH 7.4) four times to remove excess unreacted DNA.
 
=== Notes ===
* Prepare TCEP dilutions fresh; avoid exposing antibodies to low pH or high DMSO concentrations.
* Adjust reagent volumes and molar ratios according to the actual antibody concentration and the desired degree of labeling.
* Verify conjugation by an appropriate analytical method (SDS‑PAGE, absorbance/fluorescence, or mass spectrometry).
== Triplex DNA pH  Test==
*'''Stock Solution''': Dissolve in ultrapure water to 1 mM and store at −20 °C.
*'''Stock Solution''': Dissolve in ultrapure water to 1 mM and store at −20 °C.



Revision as of 09:07, 9 January 2026

Antibody conjuagted DNA

Reagents and stock solutions

  • Antibody (lexatumumab): 50 μM stock; prepare 10 μM working solution by dilution in 1× PBS.
  • TCEP: 10 mM stock; prepare 100 μM working solution by dilution in nuclease-free water.
  • Mal-PEG4-DBCO: 10 mM stock (DMSO); 1 mM working solution (DMSO).
  • SsDNA-Azide: 1 mM stock (nuclease-free water).
  • Citrate buffer: 100 mM, pH 5.5.

1. Preparation of Mal–DNA

  • Combine Mal‑PEG4‑DBCO and SsDNA at a 1:2 molar ratio. Example preparation (nominal final concentration 100 μM for Mal‑PEG4‑DBCO):
Component Volume
Mal-PEG4-DBCO (stock) 2 μL
SsDNA (stock) 4 μL
1× PBS (pH 6.5) 14 μL
  • Incubate the mixture at room temperature for 4 h.

2. Antibody reduction

  • Pre-dilute TCEP into citrate buffer (pH 5.5) before mixing with antibody to avoid antibody inactivation (TCEP stock is acidic).
  • Example reduction mixture:
Component Volume
Antibody (stock) 10 μL
TCEP (stock, pre-diluted) 5 μL
Citrate buffer (100 mM, pH 5.5) 85 μL
  • Incubate at 37 °C for 2 h to reduce disulfides and generate free thiols.
  • Remove excess TCEP and exchange buffer to 1× PBS (pH 6.5) by ultrafiltration (centrifugal concentrator), performing four washes. Target final antibody volume: ~10–30 μL.

3. Antibody–DNA conjugation

  • Because Mal‑DNA contains DMSO (~10%), dilute the Mal‑DNA in PBS prior to addition to antibody.
  • Example conjugation setup:
Component Volume / notes
Reduced antibody (from step 2) variable (see note)
Mal-DNA (prepared in step 1) 5 μL
1× PBS (pH 6.5) ~50 μL (to reach desired antibody:Mal‑DNA ratio; example uses ~1:5)
  • Incubate under appropriate conditions (e.g., room temperature for 1–4 h or 4 °C overnight) to allow maleimide–thiol coupling.
  • Purify the conjugate by ultrafiltration/washing with 1× PBS (pH 7.4) four times to remove excess unreacted DNA.

Notes

  • Prepare TCEP dilutions fresh; avoid exposing antibodies to low pH or high DMSO concentrations.
  • Adjust reagent volumes and molar ratios according to the actual antibody concentration and the desired degree of labeling.
  • Verify conjugation by an appropriate analytical method (SDS‑PAGE, absorbance/fluorescence, or mass spectrometry).

Triplex DNA pH Test

  • Stock Solution: Dissolve in ultrapure water to 1 mM and store at −20 °C.
  • Buffer: 0.5X TBE with 10 mM MgCl2 (pH: 5.5, 6.5, 7.0, 7.5, 8.5)
  • Incubation: Dilute the stock with ultrapure water to 1% (10 µM). Add 4 µL each of TFO, S1, and S2 (or S‑TFO, S‑S1, S‑S2) to 388 ul buffers of different pH and incubate at 37 °C for 3 h.
pH (388 uL) SsDNA 1 (Cy3) — 4 uL SsDNA 2 (Cy5) — 4 uL SsDNA 3 — 4 uL
5.5 TFO S1 S2
5.5 S-TFO S-S1 S-S2
6.5 TFO S1 S2
6.5 S-TFO S-S1 S-S2
7.0 TFO S1 S2
7.0 S-TFO S-S1 S-S2
7.5 TFO S1 S2
7.5 S-TFO S-S1 S-S2
8.5 TFO S1 S2
8.5 S-TFO S-S1 S-S2

Fluorometer

  • Donor-only:Cy3-only
  • Acceptor-only:Cy5-only
  • Measurement channels
  1. IDA channel: excitation 550 nm; emission 670 nm.
  2. IDD channel: excitation 550 nm; emission 570 nm.
  3. IAA channel: excitation 650 nm; emission 670 nm.

Formuals

  • α = mean(IDA_Donly / IDD_Donly)--(donor → acceptor leakage ratio)
  • β = mean(IDA_Aonly / IAA_Aonly)--(acceptor direct‑excitation by the donor excitation ratio)
  • IDA_corr = IDA_meas - α*IDD_meas − β*IAA_meas--(If the result < 0, set it to 0 .)
  • Eapp = IDA_corr / (IDA_corr + γ * IDD_meas), here γ ≈ 1-- (approximate)